Advertisement

Index by Author

January 2000; 23 (1)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Alberiche, M

    • Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care January 2000 23:57-63; doi:10.2337/diacare.23.1.57

  2. Alberti, K G

    • Impaired fasting glucose: how low should it go? Diabetes Care January 2000 23:34-39; doi:10.2337/diacare.23.1.34

  3. Andersen, R E

    • Pro115Gln peroxisome proliferator-activated receptor-gamma and obesity. Diabetes Care January 2000 23:126-127; doi:10.2337/diacare.23.1.126a

  4. Artuch, R

    • Total homocysteine in patients with type 1 diabetes. Diabetes Care January 2000 23:84-87; doi:10.2337/diacare.23.1.84

B

  1. Babka, C

    • HbA1c is not recommended as a screening test for diabetes in cystic fibrosis. Diabetes Care January 2000 23:126; doi:10.2337/diacare.23.1.126b

  2. Bayraktar, M

    • Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels. Diabetes Care January 2000 23:88-92; doi:10.2337/diacare.23.1.88

  3. Beamer, B A

    • Pro115Gln peroxisome proliferator-activated receptor-gamma and obesity. Diabetes Care January 2000 23:126-127; doi:10.2337/diacare.23.1.126a

  4. Bell, D S

    • Late-onset troglitazone-induced hepatic dysfunction. Diabetes Care January 2000 23:128-129; doi:10.2337/diacare.23.1.128

  5. Blair, S N

    • Alcohol intake and incidence of type 2 diabetes in men. Diabetes Care January 2000 23:18-22; doi:10.2337/diacare.23.1.18

  6. Bloomgarden, Z T

    • American Diabetes Association Annual Meeting, 1999: diabetes and obesity. Diabetes Care January 2000 23:118-124; doi:10.2337/diacare.23.1.118

  7. Boden-Albala, B

    • Association of hyperandrogenemia and hyperestrogenemia with type 2 diabetes in Hispanic postmenopausal women. Diabetes Care January 2000 23:74-79; doi:10.2337/diacare.23.1.74

  8. Bonadonna, R C

    • Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study. Diabetes Care January 2000 23:45-50; doi:10.2337/diacare.23.1.45
    • Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care January 2000 23:57-63; doi:10.2337/diacare.23.1.57

  9. Bonora, E

    • Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study. Diabetes Care January 2000 23:45-50; doi:10.2337/diacare.23.1.45
    • Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care January 2000 23:57-63; doi:10.2337/diacare.23.1.57

  10. Bouter, L M

    • Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories: the Hoorn Study. Diabetes Care January 2000 23:40-44; doi:10.2337/diacare.23.1.40

  11. Brancati, F L

    • Depressive symptoms and metabolic control in African-Americans with type 2 diabetes. Diabetes Care January 2000 23:23-29; doi:10.2337/diacare.23.1.23
    • Pro115Gln peroxisome proliferator-activated receptor-gamma and obesity. Diabetes Care January 2000 23:126-127; doi:10.2337/diacare.23.1.126a

  12. Brighenti, F

    • Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial. Diabetes Care January 2000 23:9-14; doi:10.2337/diacare.23.1.9

  13. Brun, E

    • Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study. Diabetes Care January 2000 23:45-50; doi:10.2337/diacare.23.1.45

  14. Buck, C

    • HbA1c is not recommended as a screening test for diabetes in cystic fibrosis. Diabetes Care January 2000 23:126; doi:10.2337/diacare.23.1.126b

  15. Burgos, R

    • Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study. Diabetes Care January 2000 23:80-83; doi:10.2337/diacare.23.1.80

C

  1. Cantón, A

    • Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study. Diabetes Care January 2000 23:80-83; doi:10.2337/diacare.23.1.80

  2. Chitson, P

    • Impaired fasting glucose: how low should it go? Diabetes Care January 2000 23:34-39; doi:10.2337/diacare.23.1.34

  3. Coleman, K J

    • Gestational diabetes: is a higher cesarean section rate inevitable? Diabetes Care January 2000 23:15-17; doi:10.2337/diacare.23.1.15

  4. Colomé, C

    • Total homocysteine in patients with type 1 diabetes. Diabetes Care January 2000 23:84-87; doi:10.2337/diacare.23.1.84

  5. Cooper-Patrick, L

    • Depressive symptoms and metabolic control in African-Americans with type 2 diabetes. Diabetes Care January 2000 23:23-29; doi:10.2337/diacare.23.1.23

  6. Crum, R M

    • Depressive symptoms and metabolic control in African-Americans with type 2 diabetes. Diabetes Care January 2000 23:23-29; doi:10.2337/diacare.23.1.23

D

  1. Dahodwala, N

    • Association of hyperandrogenemia and hyperestrogenemia with type 2 diabetes in Hispanic postmenopausal women. Diabetes Care January 2000 23:74-79; doi:10.2337/diacare.23.1.74

  2. Davis, C

    • Pancreas and islet transplantation for patients with diabetes. Diabetes Care January 2000 23:112-116; doi:10.2337/diacare.23.1.112

  3. Davis, W S

    • Gestational diabetes: is a higher cesarean section rate inevitable? Diabetes Care January 2000 23:15-17; doi:10.2337/diacare.23.1.15

  4. de Courten, M

    • Impaired fasting glucose: how low should it go? Diabetes Care January 2000 23:34-39; doi:10.2337/diacare.23.1.34

  5. Dekker, J M

    • Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories: the Hoorn Study. Diabetes Care January 2000 23:40-44; doi:10.2337/diacare.23.1.40

  6. de Vegt, F

    • Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories: the Hoorn Study. Diabetes Care January 2000 23:40-44; doi:10.2337/diacare.23.1.40

  7. Doi, K

    • Insulin secretion, insulin sensitivity, and glucose effectiveness in nonobese individuals with varying degrees of glucose tolerance. Diabetes Care January 2000 23:127-128; doi:10.2337/diacare.23.1.127

  8. Dowse, G K

    • Impaired fasting glucose: how low should it go? Diabetes Care January 2000 23:34-39; doi:10.2337/diacare.23.1.34

F

  1. Fagerudd, J A

    • Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy. Diabetes Care January 2000 23:30-33; doi:10.2337/diacare.23.1.30

  2. Ferrer, I

    • Total homocysteine in patients with type 1 diabetes. Diabetes Care January 2000 23:84-87; doi:10.2337/diacare.23.1.84

  3. Ford, D

    • Depressive symptoms and metabolic control in African-Americans with type 2 diabetes. Diabetes Care January 2000 23:23-29; doi:10.2337/diacare.23.1.23

  4. Frias, J P

    • Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects. Diabetes Care January 2000 23:64-69; doi:10.2337/diacare.23.1.64

  5. Fukushima, M

    • Insulin secretion, insulin sensitivity, and glucose effectiveness in nonobese individuals with varying degrees of glucose tolerance. Diabetes Care January 2000 23:127-128; doi:10.2337/diacare.23.1.127

G

  1. Gary, T L

    • Depressive symptoms and metabolic control in African-Americans with type 2 diabetes. Diabetes Care January 2000 23:23-29; doi:10.2337/diacare.23.1.23

  2. Gibbons, L W

    • Alcohol intake and incidence of type 2 diabetes in men. Diabetes Care January 2000 23:18-22; doi:10.2337/diacare.23.1.18

  3. Gohdes, D

    • Diabetes screening practices among individuals aged 45 years and older. Diabetes Care January 2000 23:125-126; doi:10.2337/diacare.23.1.125

  4. Gougeon, R

    • Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes. Diabetes Care January 2000 23:1-8; doi:10.2337/diacare.23.1.1

  5. Gürlek, A

    • Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels. Diabetes Care January 2000 23:88-92; doi:10.2337/diacare.23.1.88

H

  1. Harwell, T S

    • Diabetes screening practices among individuals aged 45 years and older. Diabetes Care January 2000 23:125-126; doi:10.2337/diacare.23.1.125

  2. Heine, R J

    • Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories: the Hoorn Study. Diabetes Care January 2000 23:40-44; doi:10.2337/diacare.23.1.40

  3. Helgerson, S D

    • Diabetes screening practices among individuals aged 45 years and older. Diabetes Care January 2000 23:125-126; doi:10.2337/diacare.23.1.125

  4. Hernández, C

    • Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study. Diabetes Care January 2000 23:80-83; doi:10.2337/diacare.23.1.80

  5. Hodge, A M

    • Impaired fasting glucose: how low should it go? Diabetes Care January 2000 23:34-39; doi:10.2337/diacare.23.1.34

  6. Holl, R W

    • HbA1c is not recommended as a screening test for diabetes in cystic fibrosis. Diabetes Care January 2000 23:126; doi:10.2337/diacare.23.1.126b

J

  1. Jenkins, D J

    • Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial. Diabetes Care January 2000 23:9-14; doi:10.2337/diacare.23.1.9

  2. Jing, T Y

    • Association of hyperandrogenemia and hyperestrogenemia with type 2 diabetes in Hispanic postmenopausal women. Diabetes Care January 2000 23:74-79; doi:10.2337/diacare.23.1.74

  3. Jones, P J

    • Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes. Diabetes Care January 2000 23:1-8; doi:10.2337/diacare.23.1.1

  4. Josse, R G

    • Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial. Diabetes Care January 2000 23:9-14; doi:10.2337/diacare.23.1.9

K

  1. Kampert, J B

    • Alcohol intake and incidence of type 2 diabetes in men. Diabetes Care January 2000 23:18-22; doi:10.2337/diacare.23.1.18

  2. Kao, W H

    • Pro115Gln peroxisome proliferator-activated receptor-gamma and obesity. Diabetes Care January 2000 23:126-127; doi:10.2337/diacare.23.1.126a

  3. Karhapää, P

    • Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care January 2000 23:70-73; doi:10.2337/diacare.23.1.70

  4. Kärkkäinen, P

    • Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care January 2000 23:70-73; doi:10.2337/diacare.23.1.70

  5. Kekäläinen, P

    • Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care January 2000 23:70-73; doi:10.2337/diacare.23.1.70

  6. Kimura, S

    • Glyburide-induced hemolysis in myelodysplastic syndrome. Diabetes Care January 2000 23:129; doi:10.2337/diacare.23.1.129b

  7. Kirazli, S

    • Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels. Diabetes Care January 2000 23:88-92; doi:10.2337/diacare.23.1.88

  8. Knights, S J

    • Gestational diabetes: is a higher cesarean section rate inevitable? Diabetes Care January 2000 23:15-17; doi:10.2337/diacare.23.1.15

  9. Kruszynska, Y T

    • Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects. Diabetes Care January 2000 23:64-69; doi:10.2337/diacare.23.1.64

  10. Kuusisto, J

    • Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care January 2000 23:70-73; doi:10.2337/diacare.23.1.70

L

  1. Laakso, M

    • Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care January 2000 23:70-73; doi:10.2337/diacare.23.1.70

  2. Larsen, J

    • Pancreas and islet transplantation for patients with diabetes. Diabetes Care January 2000 23:112-116; doi:10.2337/diacare.23.1.112

  3. Larson, T S

    • Trends in persistent proteinuria in adult-onset diabetes: a population-based study. Diabetes Care January 2000 23:51-56; doi:10.2337/diacare.23.1.51

  4. Leibson, C L

    • Trends in persistent proteinuria in adult-onset diabetes: a population-based study. Diabetes Care January 2000 23:51-56; doi:10.2337/diacare.23.1.51

  5. Leiter, L A

    • Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial. Diabetes Care January 2000 23:9-14; doi:10.2337/diacare.23.1.9

  6. Lin, I F

    • Association of hyperandrogenemia and hyperestrogenemia with type 2 diabetes in Hispanic postmenopausal women. Diabetes Care January 2000 23:74-79; doi:10.2337/diacare.23.1.74

  7. Lucas, E M

    • Gestational diabetes: is a higher cesarean section rate inevitable? Diabetes Care January 2000 23:15-17; doi:10.2337/diacare.23.1.15

M

  1. Mabuchi, H

    • Deterioration of glycemic control after long-term treatment with troglitazone in nonobese type 2 diabetic patients. Diabetes Care January 2000 23:131-132; doi:10.2337/diacare.23.1.131

  2. Markkanen, A

    • Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care January 2000 23:70-73; doi:10.2337/diacare.23.1.70

  3. Marliss, E B

    • Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes. Diabetes Care January 2000 23:1-8; doi:10.2337/diacare.23.1.1

  4. Mateo, C

    • Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study. Diabetes Care January 2000 23:80-83; doi:10.2337/diacare.23.1.80

  5. Maule, S

    • Effects of exposure at an altitude of 3,000 m on performance of glucose meters. Diabetes Care January 2000 23:129-131; doi:10.2337/diacare.23.1.129a

  6. McDowall, J M

    • Diabetes screening practices among individuals aged 45 years and older. Diabetes Care January 2000 23:125-126; doi:10.2337/diacare.23.1.125

  7. Melton, L J, 3rd

    • Trends in persistent proteinuria in adult-onset diabetes: a population-based study. Diabetes Care January 2000 23:51-56; doi:10.2337/diacare.23.1.51

  8. Mesa, J

    • Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study. Diabetes Care January 2000 23:80-83; doi:10.2337/diacare.23.1.80

  9. Migliardi, M

    • Effects of exposure at an altitude of 3,000 m on performance of glucose meters. Diabetes Care January 2000 23:129-131; doi:10.2337/diacare.23.1.129a

  10. Mitchell, T L

    • Alcohol intake and incidence of type 2 diabetes in men. Diabetes Care January 2000 23:18-22; doi:10.2337/diacare.23.1.18

  11. Moghetti, P

    • Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study. Diabetes Care January 2000 23:45-50; doi:10.2337/diacare.23.1.45

  12. Monauni, T

    • Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care January 2000 23:57-63; doi:10.2337/diacare.23.1.57

  13. Morais, J A

    • Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes. Diabetes Care January 2000 23:1-8; doi:10.2337/diacare.23.1.1

  14. Moses, M

    • Gestational diabetes: is a higher cesarean section rate inevitable? Diabetes Care January 2000 23:15-17; doi:10.2337/diacare.23.1.15

  15. Moses, R G

    • Gestational diabetes: is a higher cesarean section rate inevitable? Diabetes Care January 2000 23:15-17; doi:10.2337/diacare.23.1.15

  16. Muggeo, M

    • Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study. Diabetes Care January 2000 23:45-50; doi:10.2337/diacare.23.1.45
    • Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care January 2000 23:57-63; doi:10.2337/diacare.23.1.57

  17. Murase, Y

    • Deterioration of glycemic control after long-term treatment with troglitazone in nonobese type 2 diabetic patients. Diabetes Care January 2000 23:131-132; doi:10.2337/diacare.23.1.131

  18. Mykkänen, L

    • Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care January 2000 23:70-73; doi:10.2337/diacare.23.1.70

N

  1. Nagasaka, S

    • Insulin secretion, insulin sensitivity, and glucose effectiveness in nonobese individuals with varying degrees of glucose tolerance. Diabetes Care January 2000 23:127-128; doi:10.2337/diacare.23.1.127

  2. Nagata, I

    • Insulin secretion, insulin sensitivity, and glucose effectiveness in nonobese individuals with varying degrees of glucose tolerance. Diabetes Care January 2000 23:127-128; doi:10.2337/diacare.23.1.127

  3. Nakai, Y

    • Insulin secretion, insulin sensitivity, and glucose effectiveness in nonobese individuals with varying degrees of glucose tolerance. Diabetes Care January 2000 23:127-128; doi:10.2337/diacare.23.1.127

  4. Nguyen, W

    • Pro115Gln peroxisome proliferator-activated receptor-gamma and obesity. Diabetes Care January 2000 23:126-127; doi:10.2337/diacare.23.1.126a

  5. Nielsen, F S

    • Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy. Diabetes Care January 2000 23:30-33; doi:10.2337/diacare.23.1.30

  6. Nijpels, G

    • Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories: the Hoorn Study. Diabetes Care January 2000 23:40-44; doi:10.2337/diacare.23.1.40

  7. Niskanen, L

    • Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care January 2000 23:70-73; doi:10.2337/diacare.23.1.70

  8. Noto, H

    • Glyburide-induced hemolysis in myelodysplastic syndrome. Diabetes Care January 2000 23:129; doi:10.2337/diacare.23.1.129b

  9. Novokmet, R

    • Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial. Diabetes Care January 2000 23:9-14; doi:10.2337/diacare.23.1.9

O

  1. O'Brien, P C

    • Trends in persistent proteinuria in adult-onset diabetes: a population-based study. Diabetes Care January 2000 23:51-56; doi:10.2337/diacare.23.1.51

  2. Olefsky, J M

    • Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects. Diabetes Care January 2000 23:64-69; doi:10.2337/diacare.23.1.64

  3. Ovalle, F

    • Late-onset troglitazone-induced hepatic dysfunction. Diabetes Care January 2000 23:128-129; doi:10.2337/diacare.23.1.128

  4. Owen, R

    • Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial. Diabetes Care January 2000 23:9-14; doi:10.2337/diacare.23.1.9

P

  1. Palumbo, P J

    • Trends in persistent proteinuria in adult-onset diabetes: a population-based study. Diabetes Care January 2000 23:51-56; doi:10.2337/diacare.23.1.51

  2. Parving, H H

    • Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy. Diabetes Care January 2000 23:30-33; doi:10.2337/diacare.23.1.30

  3. Pavía, C

    • Total homocysteine in patients with type 1 diabetes. Diabetes Care January 2000 23:84-87; doi:10.2337/diacare.23.1.84

  4. Pecchio, O

    • Effects of exposure at an altitude of 3,000 m on performance of glucose meters. Diabetes Care January 2000 23:129-131; doi:10.2337/diacare.23.1.129a

  5. Phillips, G B

    • Association of hyperandrogenemia and hyperestrogenemia with type 2 diabetes in Hispanic postmenopausal women. Diabetes Care January 2000 23:74-79; doi:10.2337/diacare.23.1.74

  6. Pihlajamäki, J

    • Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care January 2000 23:70-73; doi:10.2337/diacare.23.1.70

  7. Poirier, O

    • Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy. Diabetes Care January 2000 23:30-33; doi:10.2337/diacare.23.1.30

  8. Poland, G A

    • Use of influenza and pneumococcal vaccines in people with diabetes. Diabetes Care January 2000 23:95-108; doi:10.2337/diacare.23.1.95

  9. Pratley, R

    • Pro115Gln peroxisome proliferator-activated receptor-gamma and obesity. Diabetes Care January 2000 23:126-127; doi:10.2337/diacare.23.1.126a

R

  1. Rissanen, J

    • Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care January 2000 23:70-73; doi:10.2337/diacare.23.1.70

  2. Robertson, R P

    • Pancreas and islet transplantation for patients with diabetes. Diabetes Care January 2000 23:112-116; doi:10.2337/diacare.23.1.112

  3. Rossing, P

    • Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy. Diabetes Care January 2000 23:30-33; doi:10.2337/diacare.23.1.30

  4. Russell, K G

    • Gestational diabetes: is a higher cesarean section rate inevitable? Diabetes Care January 2000 23:15-17; doi:10.2337/diacare.23.1.15

S

  1. Sacco, R L

    • Association of hyperandrogenemia and hyperestrogenemia with type 2 diabetes in Hispanic postmenopausal women. Diabetes Care January 2000 23:74-79; doi:10.2337/diacare.23.1.74

  2. Saggiani, F

    • Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care January 2000 23:57-63; doi:10.2337/diacare.23.1.57

  3. Sakai, M

    • Insulin secretion, insulin sensitivity, and glucose effectiveness in nonobese individuals with varying degrees of glucose tolerance. Diabetes Care January 2000 23:127-128; doi:10.2337/diacare.23.1.127

  4. Santanello, N

    • Trends in persistent proteinuria in adult-onset diabetes: a population-based study. Diabetes Care January 2000 23:51-56; doi:10.2337/diacare.23.1.51

  5. Shahinfar, S

    • Trends in persistent proteinuria in adult-onset diabetes: a population-based study. Diabetes Care January 2000 23:51-56; doi:10.2337/diacare.23.1.51

  6. Shaw, J E

    • Impaired fasting glucose: how low should it go? Diabetes Care January 2000 23:34-39; doi:10.2337/diacare.23.1.34

  7. Shuldiner, A R

    • Pro115Gln peroxisome proliferator-activated receptor-gamma and obesity. Diabetes Care January 2000 23:126-127; doi:10.2337/diacare.23.1.126a

  8. Sievenpiper, J L

    • Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial. Diabetes Care January 2000 23:9-14; doi:10.2337/diacare.23.1.9

  9. Simó, R

    • Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study. Diabetes Care January 2000 23:80-83; doi:10.2337/diacare.23.1.80

  10. Smilie, J G

    • Diabetes screening practices among individuals aged 45 years and older. Diabetes Care January 2000 23:125-126; doi:10.2337/diacare.23.1.125

  11. Smith, S A

    • Use of influenza and pneumococcal vaccines in people with diabetes. Diabetes Care January 2000 23:95-108; doi:10.2337/diacare.23.1.95

  12. Spadafora, P

    • Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial. Diabetes Care January 2000 23:9-14; doi:10.2337/diacare.23.1.9

  13. Stehouwer, C D

    • Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories: the Hoorn Study. Diabetes Care January 2000 23:40-44; doi:10.2337/diacare.23.1.40

  14. Stratta, R

    • Pancreas and islet transplantation for patients with diabetes. Diabetes Care January 2000 23:112-116; doi:10.2337/diacare.23.1.112

  15. Styhler, K

    • Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes. Diabetes Care January 2000 23:1-8; doi:10.2337/diacare.23.1.1

  16. Sutherland, D E

    • Pancreas and islet transplantation for patients with diabetes. Diabetes Care January 2000 23:112-116; doi:10.2337/diacare.23.1.112

  17. Swilley, J A

    • Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial. Diabetes Care January 2000 23:9-14; doi:10.2337/diacare.23.1.9

T

  1. Taniguchi, A

    • Insulin secretion, insulin sensitivity, and glucose effectiveness in nonobese individuals with varying degrees of glucose tolerance. Diabetes Care January 2000 23:127-128; doi:10.2337/diacare.23.1.127

  2. Targher, G

    • Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care January 2000 23:57-63; doi:10.2337/diacare.23.1.57

  3. Tarnow, L

    • Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy. Diabetes Care January 2000 23:30-33; doi:10.2337/diacare.23.1.30

  4. Thon, A

    • HbA1c is not recommended as a screening test for diabetes in cystic fibrosis. Diabetes Care January 2000 23:126; doi:10.2337/diacare.23.1.126b

  5. Tokuyama, K

    • Insulin secretion, insulin sensitivity, and glucose effectiveness in nonobese individuals with varying degrees of glucose tolerance. Diabetes Care January 2000 23:127-128; doi:10.2337/diacare.23.1.127

  6. Trento, M

    • Effects of exposure at an altitude of 3,000 m on performance of glucose meters. Diabetes Care January 2000 23:129-131; doi:10.2337/diacare.23.1.129a

  7. Tsukamoto, K

    • Glyburide-induced hemolysis in myelodysplastic syndrome. Diabetes Care January 2000 23:129; doi:10.2337/diacare.23.1.129b

  8. Tuck, C H

    • Association of hyperandrogenemia and hyperestrogenemia with type 2 diabetes in Hispanic postmenopausal women. Diabetes Care January 2000 23:74-79; doi:10.2337/diacare.23.1.74

  9. Tuomilehto, J

    • Impaired fasting glucose: how low should it go? Diabetes Care January 2000 23:34-39; doi:10.2337/diacare.23.1.34

V

  1. Valls, C

    • Total homocysteine in patients with type 1 diabetes. Diabetes Care January 2000 23:84-87; doi:10.2337/diacare.23.1.84

  2. Veglio, M

    • Effects of exposure at an altitude of 3,000 m on performance of glucose meters. Diabetes Care January 2000 23:129-131; doi:10.2337/diacare.23.1.129a

  3. Verlato, G

    • Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study. Diabetes Care January 2000 23:45-50; doi:10.2337/diacare.23.1.45

  4. Vidgen, E

    • Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial. Diabetes Care January 2000 23:9-14; doi:10.2337/diacare.23.1.9

  5. Vilaseca, M A

    • Total homocysteine in patients with type 1 diabetes. Diabetes Care January 2000 23:84-87; doi:10.2337/diacare.23.1.84

  6. Vuksan, V

    • Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial. Diabetes Care January 2000 23:9-14; doi:10.2337/diacare.23.1.9

W

  1. Wakasugi, T

    • Deterioration of glycemic control after long-term treatment with troglitazone in nonobese type 2 diabetic patients. Diabetes Care January 2000 23:131-132; doi:10.2337/diacare.23.1.131

  2. Wei, M

    • Alcohol intake and incidence of type 2 diabetes in men. Diabetes Care January 2000 23:18-22; doi:10.2337/diacare.23.1.18

  3. Wolf, A

    • HbA1c is not recommended as a screening test for diabetes in cystic fibrosis. Diabetes Care January 2000 23:126; doi:10.2337/diacare.23.1.126b

X

  1. Xu, Z

    • Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial. Diabetes Care January 2000 23:9-14; doi:10.2337/diacare.23.1.9

Y

  1. Yagi, K

    • Deterioration of glycemic control after long-term treatment with troglitazone in nonobese type 2 diabetic patients. Diabetes Care January 2000 23:131-132; doi:10.2337/diacare.23.1.131

  2. Yu, J G

    • Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects. Diabetes Care January 2000 23:64-69; doi:10.2337/diacare.23.1.64

Z

  1. Zenere, M B

    • Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care January 2000 23:57-63; doi:10.2337/diacare.23.1.57

  2. Zimmet, P Z

    • Impaired fasting glucose: how low should it go? Diabetes Care January 2000 23:34-39; doi:10.2337/diacare.23.1.34

  3. Zoppini, G

    • Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study. Diabetes Care January 2000 23:45-50; doi:10.2337/diacare.23.1.45

Current Issue

  1. February 2012, 35 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care
Advertisement